BIIB: Biogen Inc Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 62,436.56
Enterprise Value ($M) 69,684.76
Book Value ($M) 10,682.20
Book Value / Share 70.95
Price / Book 5.84
NCAV ($M) -6,472.00
NCAV / Share -42.99
Price / NCAV -9.65

Profitability (mra)
Return on Invested Capital (ROIC) 0.22
Return on Assets (ROA) 0.15
Return on Equity (ROE) 0.30

Liquidity (mrq)
Quick Ratio 1.75
Current Ratio 2.12

Balance Sheet (mrq) ($M)
Current Assets 6,719.50
Assets 23,854.70
Liabilities 13,191.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 13,444.60
Operating Income 4,550.10
Net Income 4,060.50
Earnings Per Share Diluted 24.80
Earnings Per Share Basic 24.86

Cash Flow Statement (mra) ($M)
Cash From Operations 4,229.80
Cash from Investing -608.60
Cash from Financing -608.60

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-12 13G/A Primecap Management Co/ca/ 10.28 -0.41
02-10 13G/A Vanguard Group Inc 7.73 -14.23
01-29 13G/A BlackRock Inc. 8.70 -14.30

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-04-22 10-Q Quarterly Report – 10-Q
2021-02-03 10-K Annual Report – 10-K
2020-10-21 10-Q Quarterly Report – 10-Q
2020-07-22 10-Q Quarterly Report – 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2021-06-11 907,830 4,221,500 21.50
2021-06-10 974,130 4,752,800 20.50
2021-06-09 1,862,844 6,196,300 30.06
2021-06-08 4,125,880 12,208,500 33.80
2021-06-07 4,771,886 17,946,000 26.59

(click for more detail)

(click for list of largest short owners)

Similar Companies
BEAM – Beam Therapeutics Inc BFRA – Biofrontera AG
BGNE – BeiGene, Ltd. BIVI – BioVie Inc
BLCM – Bellicum Pharmaceuticals Inc


Financial data and stock pages provided by
Fintel.io